With CBD's US Consumer Health Future In Limbo, FDA Warns About Injectable Offered OTC
Executive Summary
With the rapid growth of CBD supplements, topicals and other consumer health products available in the US, FDA has found no shortage of businesses to warn about making noncompliant claims. Still, it previously hasn't found reason to warn CBD businesses about unsafe delivery formats.